Stock Events

Stock Events

Check-Cap 

$1.82
0
+$0.02+1.11% Thursday 20:00

Statistics

Day High
2.18
Day Low
1.67
52W High
3.92
52W Low
0.59
Volume
95,452
Avg. Volume
2,525,957
Mkt Cap
10.65M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

1JanExpected
Q4 0
-0.4
-0.07
0.27
0.6
Expected EPS
-0.4
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-50.3MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MBAI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Exact Sciences
EXAS
Mkt Cap12.25B
Exact Sciences offers Cologuard, a non-invasive colon cancer screening test, directly competing with Check-Cap's capsule-based screening technology.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical specializes in robotic-assisted surgery, offering an alternative to Check-Cap's non-invasive approach by providing minimally invasive surgical options.
Medtronic
MDT
Mkt Cap116.33B
Medtronic offers a broad range of medical devices that include gastrointestinal and endoscopic products, competing with Check-Cap in the broader market for diagnostic solutions.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific produces endoscopy equipment and devices, offering competitive technologies for diagnosing and managing gastrointestinal conditions.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health offers liquid biopsy tests for cancer detection, providing a non-invasive alternative to traditional and emerging diagnostic methods, including Check-Cap's.
NovoCure
NVCR
Mkt Cap1.43B
NovoCure develops treatment for cancer using Tumor Treating Fields, a different approach but competes for the same oncology market as Check-Cap's diagnostic solutions.
Stryker
SYK
Mkt Cap136.19B
Stryker specializes in medical technologies, including endoscopic and surgical devices, competing in the broader market for medical devices that can be used in diagnosis and treatment of gastrointestinal diseases.

About

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel.
Show more...
CEO
ISIN
IL0011336851

Listings

F
DE
7CC.F
BOATS
BOATS
MBAI.BOATS
XNAS
US
CHEK
XNAS
US
MBAI

0 Comments

Share your thoughts

FAQ

What is Check-Cap stock price today?▼
The current price of MBAI is $1.82 USD — it has increased by +1.11% in the past 24 hours. Watch Check-Cap stock price performance more closely on the chart.
What is Check-Cap stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Check-Cap stocks are traded under the ticker MBAI.
What is Check-Cap market cap?▼
Today Check-Cap has the market capitalization of 10.65M
What is Check-Cap revenue for the last year?▼
Check-Cap revenue for the last year amounts to 0 USD.
What is Check-Cap net income for the last year?▼
MBAI net income for the last year is -50.3M USD.
When did Check-Cap complete a stock split?▼
Check-Cap has not had any recent stock splits.